These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33445150)

  • 1. Loco-regional adjuvant radiation therapy in breast cancer patients with positive axillary lymph-nodes at diagnosis (CN2) undergoing preoperative chemotherapy and with complete pathological lymph-nodes response. Development of GRADE (Grades of recommendation, assessment, Development and Evaluation) recommendation by the Italian Association of radiation therapy and Clinical Oncology (AIRO).
    Marino L; Lancellotta V; Franco P; Meattini I; Meduri B; Bernini M; Fabi A; Corvò R; Magrini SM; Pappagallo GL; Arcangeli S; D'Angelillo RM
    Breast; 2021 Feb; 55():119-127. PubMed ID: 33445150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: an indication for radiotherapy?
    Fisher BJ; Perera FE; Cooke AL; Opeitum A; Dar AR; Venkatesan VM; Stitt L; Radwan JS
    Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):551-9. PubMed ID: 9231679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative loco-regional radiation therapy for breast cancer patients with four or more involved lymph nodes or extracapsular extension.
    Evron E; Barzily L; Rakowsky E; Ben-Baruch N; Sulkes J; Rizel S; Fenig E
    Isr Med Assoc J; 2005 Jul; 7(7):439-42. PubMed ID: 16011059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-mastectomy radiotherapy for women with early breast cancer and one to three positive lymph nodes.
    Verma R; Chandarana M; Barrett J; Anandadas C; Sundara Rajan S
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD014463. PubMed ID: 37327075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axillary treatment for operable primary breast cancer.
    Bromham N; Schmidt-Hansen M; Astin M; Hasler E; Reed MW
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004561. PubMed ID: 28052186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can the addition of regional radiotherapy counterbalance important risk factors in breast cancer patients with extracapsular invasion of axillary lymph node metastases?
    Gruber G; Berclaz G; Altermatt HJ; Greiner RH
    Strahlenther Onkol; 2003 Oct; 179(10):661-6. PubMed ID: 14566473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which target volume should be considered when irradiating the regional nodes in breast cancer? Results of a network-meta-analysis.
    Haussmann J; Budach W; Tamaskovics B; Bölke E; Corradini S; Djiepmo-Njanang FJ; Kammers K; Matuschek C
    Radiat Oncol; 2019 Jun; 14(1):102. PubMed ID: 31186015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taxanes for adjuvant treatment of early breast cancer.
    Willson ML; Burke L; Ferguson T; Ghersi D; Nowak AK; Wilcken N
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD004421. PubMed ID: 31476253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial breast irradiation for early breast cancer.
    Hickey BE; Lehman M; Francis DP; See AM
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD007077. PubMed ID: 27425375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation therapy and survival in breast cancer patients with 10 or more positive axillary lymph nodes treated with mastectomy.
    Diab SG; Hilsenbeck SG; de Moor C; Clark GM; Osborne CK; Ravdin PM; Elledge RM
    J Clin Oncol; 1998 May; 16(5):1655-60. PubMed ID: 9586875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer.
    Bui KT; Willson ML; Goel S; Beith J; Goodwin A
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013538. PubMed ID: 32141074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-mastectomy radiation therapy in HER-2 positive breast cancer after primary systemic therapy: Pooled analysis of TRYPHAENA and NeoSphere trials.
    Saifi O; Bachir B; Panoff J; Poortmans P; Zeidan YH
    Radiother Oncol; 2023 Jul; 184():109668. PubMed ID: 37030399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possibility of conservative local treatment after combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer.
    Touboul E; Buffat L; Lefranc JP; Blondon J; Deniaud E; Mammar H; Laugier A; Schlienger M
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1019-28. PubMed ID: 8600084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loco-regional control after neo-adjuvant chemotherapy and conservative treatment for locally advanced breast cancer patients.
    Levy A; Borget I; Bahri M; Arnedos M; Rivin E; Vielh P; Balleyguier C; Rimareix F; Bourgier C
    Breast J; 2014; 20(4):381-7. PubMed ID: 24890310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis.
    Rusthoven CG; Rabinovitch RA; Jones BL; Koshy M; Amini A; Yeh N; Jackson MW; Fisher CM
    Ann Oncol; 2016 May; 27(5):818-27. PubMed ID: 26861597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting loco-regional recurrence risk in T1, T2 breast cancer with 1-3 positive axillary nodes postmastectomy: Development of a predictive nomogram.
    Wadasadawala T; Kannan S; Gudi S; Rishi A; Budrukkar A; Parmar V; Shet T; Desai S; Gupta S; Badwe R; Sarin R
    Indian J Cancer; 2017; 54(1):352-357. PubMed ID: 29199721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capecitabine for hormone receptor-positive versus hormone receptor-negative breast cancer.
    Hoon SN; Lau PK; White AM; Bulsara MK; Banks PD; Redfern AD
    Cochrane Database Syst Rev; 2021 May; 5(5):CD011220. PubMed ID: 34037241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of local-regional radiotherapy with conventional or high-dose chemotherapy in the management of breast cancer patients with > or = 10 positive axillary nodes.
    Jabro G; Wazer DE; Ruthazer R; Lum R; Sklar N; Goldman D; Enegess D; Erban J
    Int J Radiat Oncol Biol Phys; 1999 May; 44(2):273-80. PubMed ID: 10760419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loco-regional morbidity after breast conservation and axillary lymph node dissection for early breast cancer with or without regional nodes radiotherapy, perspectives in modern breast cancer treatment: the Skagen Trial 1 is active.
    Nielsen HM; Friis RB; Linnet S; Offersen BV
    Acta Oncol; 2017 May; 56(5):713-718. PubMed ID: 28105873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.